Drug intelligence / Profile preview

bacitracin zinc + lidocaine hydrochloride + neomycin sulfate + polymyxin b sulfate

Development stage
Approved
Lead developer
Johnson & Johnson
Modality
Peptides, Small Molecules
Administration
Topical
01

Overview

**Bacitracin zinc + lidocaine hydrochloride + neomycin sulfate + polymyxin B sulfate** is a fixed-dose topical OTC first-aid ointment combining three antibacterial agents with a local anesthetic. Bacitracin disrupts bacterial cell-wall synthesis by binding undecaprenyl pyrophosphate; neomycin binds the bacterial 30S ribosomal subunit and inhibits protein synthesis; polymyxin B disrupts susceptible Gram-negative bacterial membranes through interaction with lipopolysaccharide; and lidocaine reversibly blocks voltage-gated sodium channels to provide local analgesia. U.S. product labels describe use on the skin to help prevent infection and temporarily relieve pain or discomfort from minor cuts, scrapes, and burns. The exact four-ingredient topical combination should not be conflated with lidocaine 2% urethral jelly, which is a different formulation used for painful urethritis and urethral procedures. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e450b6a1-a8da-e5db-e053-2995a90a0ef0))

Brand names
Neosporin Plus LidocaineTriple Antibiotic Plus LidocaineBiotic-PlusFirst Aid Triple Antibiotic with Pain Reliever
Other names
neomycin and polymyxin b sulfates + bacitracin zinc + lidocaine ointmenttriple antibiotic plus lidocaine
02

Targets

Bacterial RibosomeC55-PP (Undecaprenyl pyrophosphate)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on bacitracin zinc + lidocaine hydrochloride + neomycin sulfate + polymyxin b sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bacitracin zinc + lidocaine hydrochloride + neomycin sulfate + polymyxin b sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call